| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Non-ST Elevated Myocardial Infarction | 10 | 2021 | 490 | 2.95 | Why? |
| Myocardial Infarction | 11 | 2021 | 3361 | 1.77 | Why? |
| ST Elevation Myocardial Infarction | 12 | 2021 | 3051 | 1.39 | Why? |
| Acute Coronary Syndrome | 11 | 2021 | 2107 | 1.25 | Why? |
| Adrenergic beta-Antagonists | 4 | 2019 | 465 | 1.24 | Why? |
| Wales | 9 | 2021 | 758 | 1.12 | Why? |
| Registries | 27 | 2021 | 12327 | 1.09 | Why? |
| England | 22 | 2021 | 5116 | 1.02 | Why? |
| Suicide, Attempted | 2 | 2018 | 599 | 0.89 | Why? |
| Cause of Death | 9 | 2021 | 4823 | 0.85 | Why? |
| Cardiovascular Agents | 4 | 2021 | 663 | 0.81 | Why? |
| Euthanasia | 1 | 2019 | 21 | 0.80 | Why? |
| Suicide, Assisted | 1 | 2019 | 36 | 0.77 | Why? |
| Percutaneous Coronary Intervention | 10 | 2021 | 3646 | 0.76 | Why? |
| Heart Failure | 9 | 2021 | 6638 | 0.74 | Why? |
| Endocarditis | 2 | 2019 | 368 | 0.66 | Why? |
| Perinatal Care | 2 | 2020 | 576 | 0.65 | Why? |
| Ventricular Dysfunction | 1 | 2017 | 150 | 0.61 | Why? |
| Life Expectancy | 1 | 2018 | 474 | 0.48 | Why? |
| Mortality | 6 | 2021 | 7132 | 0.47 | Why? |
| Intensive Care Units, Neonatal | 1 | 2018 | 749 | 0.46 | Why? |
| Risk Assessment | 15 | 2021 | 25439 | 0.45 | Why? |
| United Kingdom | 17 | 2021 | 18046 | 0.45 | Why? |
| Hospital Mortality | 14 | 2021 | 22087 | 0.44 | Why? |
| Hospitalization | 14 | 2021 | 54280 | 0.42 | Why? |
| Renal Insufficiency | 1 | 2018 | 810 | 0.42 | Why? |
| Psychiatry | 2 | 2019 | 1289 | 0.40 | Why? |
| Cardiac Rehabilitation | 1 | 2016 | 525 | 0.40 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.39 | Why? |
| Home Care Services | 1 | 2021 | 1351 | 0.39 | Why? |
| National Health Programs | 1 | 2016 | 807 | 0.38 | Why? |
| Coronary Angiography | 7 | 2021 | 2275 | 0.37 | Why? |
| Frailty | 2 | 2018 | 1432 | 0.36 | Why? |
| Quality Indicators, Health Care | 3 | 2019 | 580 | 0.36 | Why? |
| Antidepressive Agents | 1 | 2013 | 509 | 0.34 | Why? |
| Aortic Valve Stenosis | 3 | 2021 | 741 | 0.31 | Why? |
| Transcatheter Aortic Valve Replacement | 3 | 2021 | 839 | 0.29 | Why? |
| Suicide | 1 | 2018 | 1500 | 0.29 | Why? |
| Parents | 1 | 2018 | 2758 | 0.26 | Why? |
| Electrocardiography | 5 | 2018 | 3957 | 0.26 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.26 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.26 | Why? |
| Heart Diseases | 1 | 2021 | 3503 | 0.26 | Why? |
| Survival Rate | 8 | 2020 | 9206 | 0.26 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.25 | Why? |
| Long QT Syndrome | 1 | 2013 | 1047 | 0.25 | Why? |
| Secondary Prevention | 2 | 2019 | 762 | 0.24 | Why? |
| Infant, Premature | 2 | 2018 | 883 | 0.24 | Why? |
| Humans | 76 | 2021 | 930598 | 0.24 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.24 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.24 | Why? |
| Aged | 36 | 2021 | 215776 | 0.24 | Why? |
| Disease Management | 2 | 2017 | 6841 | 0.23 | Why? |
| Infant, Newborn | 9 | 2021 | 23105 | 0.23 | Why? |
| Attitude of Health Personnel | 2 | 2019 | 4741 | 0.23 | Why? |
| Female | 49 | 2021 | 380317 | 0.22 | Why? |
| Male | 46 | 2021 | 367725 | 0.21 | Why? |
| Cohort Studies | 10 | 2021 | 36005 | 0.21 | Why? |
| Medical Audit | 2 | 2020 | 218 | 0.21 | Why? |
| Pregnancy Complications, Infectious | 3 | 2020 | 11559 | 0.21 | Why? |
| Myocardial Reperfusion | 2 | 2020 | 168 | 0.20 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2021 | 144 | 0.20 | Why? |
| Neonatology | 1 | 2020 | 84 | 0.20 | Why? |
| Risk Factors | 21 | 2021 | 71621 | 0.20 | Why? |
| Stroke | 2 | 2020 | 8839 | 0.20 | Why? |
| Infant, Premature, Diseases | 1 | 2019 | 74 | 0.19 | Why? |
| Out-of-Hospital Cardiac Arrest | 2 | 2020 | 1047 | 0.19 | Why? |
| Watchful Waiting | 1 | 2021 | 276 | 0.18 | Why? |
| Therapeutic Equivalency | 1 | 2018 | 64 | 0.18 | Why? |
| Delivery Rooms | 1 | 2019 | 148 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.18 | Why? |
| Aged, 80 and over | 16 | 2021 | 88759 | 0.18 | Why? |
| Time Factors | 12 | 2020 | 31397 | 0.18 | Why? |
| Quality of Health Care | 3 | 2021 | 1948 | 0.18 | Why? |
| Glycemic Load | 1 | 2017 | 9 | 0.18 | Why? |
| Intensive Care, Neonatal | 1 | 2020 | 284 | 0.17 | Why? |
| Healthcare Disparities | 3 | 2021 | 3893 | 0.17 | Why? |
| Infant, Very Low Birth Weight | 1 | 2018 | 62 | 0.17 | Why? |
| Enterocolitis, Necrotizing | 1 | 2018 | 71 | 0.17 | Why? |
| Cardiovascular Surgical Procedures | 1 | 2021 | 281 | 0.17 | Why? |
| Practice Guidelines as Topic | 5 | 2020 | 15421 | 0.17 | Why? |
| Infant Care | 1 | 2020 | 178 | 0.17 | Why? |
| Cardiovascular Diseases | 6 | 2021 | 11497 | 0.17 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.17 | Why? |
| Social Environment | 1 | 2021 | 389 | 0.17 | Why? |
| Competency-Based Education | 1 | 2018 | 111 | 0.17 | Why? |
| Incidence | 10 | 2021 | 25622 | 0.17 | Why? |
| Middle Aged | 34 | 2021 | 270681 | 0.17 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.17 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.16 | Why? |
| Follow-Up Studies | 5 | 2020 | 17020 | 0.16 | Why? |
| Causality | 1 | 2020 | 857 | 0.16 | Why? |
| Neoplasms | 3 | 2021 | 17251 | 0.16 | Why? |
| Hospice Care | 1 | 2021 | 347 | 0.16 | Why? |
| Glycemic Index | 1 | 2017 | 115 | 0.16 | Why? |
| Parenteral Nutrition | 1 | 2018 | 184 | 0.16 | Why? |
| Neonatal Screening | 1 | 2019 | 285 | 0.15 | Why? |
| Hospitals, Low-Volume | 1 | 2017 | 355 | 0.15 | Why? |
| Sodium Benzoate | 1 | 2014 | 1 | 0.15 | Why? |
| Food Preservatives | 1 | 2014 | 2 | 0.15 | Why? |
| D-Amino-Acid Oxidase | 1 | 2014 | 2 | 0.15 | Why? |
| Time | 1 | 2018 | 631 | 0.15 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.14 | Why? |
| Coronary Artery Bypass | 1 | 2021 | 629 | 0.14 | Why? |
| Brain Injuries | 1 | 2019 | 374 | 0.14 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.14 | Why? |
| Drug Costs | 1 | 2018 | 313 | 0.14 | Why? |
| Medication Therapy Management | 1 | 2018 | 312 | 0.14 | Why? |
| Diagnostic Errors | 1 | 2021 | 865 | 0.14 | Why? |
| Oximetry | 1 | 2019 | 658 | 0.14 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.13 | Why? |
| Coronary Artery Disease | 2 | 2021 | 2570 | 0.13 | Why? |
| Clozapine | 1 | 2017 | 218 | 0.13 | Why? |
| Body Composition | 1 | 2018 | 414 | 0.13 | Why? |
| Treatment Outcome | 13 | 2021 | 51732 | 0.13 | Why? |
| Potassium Channel Blockers | 1 | 2013 | 22 | 0.13 | Why? |
| Acute Disease | 4 | 2019 | 6029 | 0.13 | Why? |
| Potassium Channels | 1 | 2013 | 33 | 0.13 | Why? |
| Aggression | 1 | 2014 | 126 | 0.13 | Why? |
| Cell Phone | 1 | 2021 | 750 | 0.13 | Why? |
| Hospitals, High-Volume | 1 | 2017 | 688 | 0.13 | Why? |
| Benchmarking | 1 | 2017 | 627 | 0.12 | Why? |
| History, 20th Century | 1 | 2019 | 1282 | 0.12 | Why? |
| Multimorbidity | 1 | 2018 | 703 | 0.12 | Why? |
| Patient Transfer | 1 | 2019 | 898 | 0.12 | Why? |
| Ventricular Function, Left | 2 | 2019 | 1555 | 0.12 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.12 | Why? |
| Propensity Score | 2 | 2019 | 2690 | 0.12 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.12 | Why? |
| Premature Birth | 2 | 2020 | 2151 | 0.11 | Why? |
| Obstetrics | 1 | 2020 | 859 | 0.11 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.11 | Why? |
| Action Potentials | 1 | 2013 | 368 | 0.11 | Why? |
| Coronary Disease | 1 | 2017 | 645 | 0.11 | Why? |
| Pregnancy Outcome | 2 | 2021 | 3803 | 0.11 | Why? |
| Cancer Survivors | 1 | 2017 | 588 | 0.10 | Why? |
| Critical Pathways | 1 | 2021 | 1587 | 0.10 | Why? |
| Survival Analysis | 3 | 2019 | 7592 | 0.10 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.10 | Why? |
| Heart Defects, Congenital | 1 | 2019 | 933 | 0.10 | Why? |
| Adult | 17 | 2021 | 244371 | 0.10 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.10 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.10 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Cognition Disorders | 1 | 2014 | 574 | 0.10 | Why? |
| Professional-Patient Relations | 1 | 2014 | 426 | 0.09 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Sex Characteristics | 1 | 2017 | 1120 | 0.09 | Why? |
| Decision Support Techniques | 1 | 2016 | 903 | 0.09 | Why? |
| Atrial Fibrillation | 2 | 2021 | 2320 | 0.09 | Why? |
| Cardiology | 2 | 2021 | 2873 | 0.09 | Why? |
| Risk | 2 | 2018 | 5288 | 0.09 | Why? |
| Depression | 1 | 2013 | 14116 | 0.09 | Why? |
| Noncommunicable Diseases | 1 | 2018 | 934 | 0.09 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
| Income | 1 | 2018 | 1564 | 0.09 | Why? |
| Violence | 1 | 2014 | 534 | 0.09 | Why? |
| Research | 1 | 2021 | 2115 | 0.09 | Why? |
| Pregnancy | 5 | 2021 | 23879 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Socioeconomic Factors | 3 | 2020 | 8495 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2018 | 1549 | 0.08 | Why? |
| Electronic Health Records | 4 | 2021 | 3492 | 0.08 | Why? |
| Antipsychotic Agents | 1 | 2014 | 887 | 0.07 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.07 | Why? |
| Fibrinolytic Agents | 1 | 2017 | 1702 | 0.07 | Why? |
| Pediatrics | 1 | 2021 | 2969 | 0.07 | Why? |
| Pneumonia, Viral | 8 | 2021 | 243684 | 0.07 | Why? |
| Patient Care Management | 1 | 2016 | 1514 | 0.07 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Noninvasive Ventilation | 1 | 2018 | 2329 | 0.07 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.07 | Why? |
| Diet | 1 | 2017 | 2052 | 0.07 | Why? |
| Schizophrenia | 1 | 2014 | 1018 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.07 | Why? |
| Education, Medical, Graduate | 1 | 2018 | 2082 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2017 | 2043 | 0.06 | Why? |
| Gestational Age | 2 | 2019 | 1488 | 0.06 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.06 | Why? |
| Sweden | 2 | 2021 | 1969 | 0.06 | Why? |
| Antirheumatic Agents | 1 | 2017 | 3023 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Social Control Policies | 1 | 2021 | 54 | 0.05 | Why? |
| Prognosis | 4 | 2018 | 32490 | 0.05 | Why? |
| Personnel, Hospital | 1 | 2014 | 2273 | 0.05 | Why? |
| Clinical Audit | 1 | 2021 | 204 | 0.05 | Why? |
| Exercise | 1 | 2021 | 6771 | 0.05 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.05 | Why? |
| Cesarean Section | 2 | 2021 | 2089 | 0.05 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.05 | Why? |
| Angina Pectoris | 1 | 2020 | 114 | 0.05 | Why? |
| Angina, Unstable | 1 | 2020 | 110 | 0.05 | Why? |
| Minority Groups | 2 | 2021 | 1631 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| New Zealand | 2 | 2018 | 2073 | 0.05 | Why? |
| Time-to-Treatment | 3 | 2020 | 5883 | 0.05 | Why? |
| Soybean Oil | 1 | 2018 | 6 | 0.05 | Why? |
| Infant, Extremely Premature | 1 | 2019 | 144 | 0.05 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.05 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.05 | Why? |
| Fat Emulsions, Intravenous | 1 | 2018 | 14 | 0.05 | Why? |
| Primary Health Care | 1 | 2016 | 4839 | 0.04 | Why? |
| Myocardial Revascularization | 1 | 2020 | 267 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Occupational Health | 1 | 2014 | 3965 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Infant Mortality | 1 | 2019 | 268 | 0.04 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2021 | 365 | 0.04 | Why? |
| Finland | 1 | 2019 | 671 | 0.04 | Why? |
| Etanercept | 1 | 2017 | 162 | 0.04 | Why? |
| Heart Valve Prosthesis | 1 | 2021 | 533 | 0.04 | Why? |
| Needs Assessment | 2 | 2016 | 2352 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Child | 3 | 2021 | 70012 | 0.03 | Why? |
| Statistics as Topic | 1 | 2016 | 370 | 0.03 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.03 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.03 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.03 | Why? |
| Symptom Flare Up | 1 | 2016 | 432 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Adalimumab | 1 | 2017 | 389 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.03 | Why? |
| Societies, Medical | 2 | 2019 | 6907 | 0.03 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2014 | 961 | 0.03 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Infant | 3 | 2019 | 30274 | 0.03 | Why? |
| Israel | 1 | 2019 | 2751 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Stroke Volume | 1 | 2019 | 2153 | 0.02 | Why? |
| Hospitals, Public | 1 | 2014 | 774 | 0.02 | Why? |
| Guideline Adherence | 1 | 2021 | 2309 | 0.02 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.02 | Why? |
| Pregnant Women | 1 | 2021 | 2535 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2021 | 3419 | 0.02 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.02 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.02 | Why? |
| Cost of Illness | 1 | 2016 | 1903 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| ROC Curve | 1 | 2016 | 6024 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Canada | 1 | 2017 | 6018 | 0.02 | Why? |
| Global Health | 2 | 2018 | 13911 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.01 | Why? |
| Survivors | 1 | 2014 | 2619 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 5277 | 0.01 | Why? |
| Ambulatory Care | 1 | 2016 | 4947 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Child, Preschool | 1 | 2014 | 36283 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2014 | 43792 | 0.00 | Why? |